TY  - JOUR
AU  - Olías-Molero, A. I.
AU  - Corral-Caridad, M. J.
AU  - Jiménez-Antón, M. D.
AU  - Mateo Barrientos, Marta
AU  - Carrión, J.
AU  - Torrado Durán, Juan José
AU  - Alunda Rodríguez, José María
PY  - 2026
DO  - 10.3389/fddsv.2026.1754269
UR  - https://hdl.handle.net/20.500.14352/134063
T2  - Frontiers in Drug Discovery
AB  - Chemotherapy of leishmaniasis, both human and canine, is far from ideal and new antileishmanial drugs are urgently needed. Therapeutic arsenal against the disease is old, of low antileishmanial efficacy and hampered by toxicity issues in some cases....
LA  - eng
M2  - 1
PB  - Frontiers Media
KW  - 3R principles
KW  - Dog
KW  - Drug development
KW  - Drugs
KW  - Experimental model
KW  - Infection
KW  - Infection follow-up
KW  - Leishmaniasis
TI  - Standardization of canine infections for the development of antileishmanial drugs
TY  - journal article
VL  - 6
ER  -